Figure 2From: Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial Tigecycline clinical cure rates compared to previous intra-abdominal studies (301, 306): (a) microbiologically evaluable (ME) and (b) microbiologic modified intent-to-treat (m-mITT) populations. Error bars indicate 95% confidence intervals, unweighted and calculated using the method of Clopper and Pearson.Back to article page